| Delineation of the molecular basis for selenium-induced growth arrest in human prostate cancer cells by oligonucleotide array Y Dong, H Zhang, L Hawthorn, HE Ganther, C Ip Cancer Research 63 (1), 52-59, 2003 | 261 | 2003 |
| New concepts in selenium chemoprevention C Ip, Y Dong, HE Ganther Cancer and Metastasis Reviews 21, 281-289, 2002 | 245 | 2002 |
| Conjugated linoleic acid isomers and mammary cancer prevention C Ip, Y Dong, MM Ip, S Banni, G Carta, E Angioni, E Murru, S Spada, ... Nutrition and cancer 43 (1), 52-58, 2002 | 218 | 2002 |
| Androgen receptor splice variants dimerize to transactivate target genes D Xu, Y Zhan, Y Qi, B Cao, S Bai, W Xu, SS Gambhir, P Lee, O Sartor, ... Cancer research 75 (17), 3663-3671, 2015 | 211 | 2015 |
| Androgen receptor splice variants activating the full-length receptor in mediating resistance to androgen-directed therapy B Cao, Y Qi, G Zhang, D Xu, Y Zhan, X Alvarez, Z Guo, X Fu, SR Plymate, ... Oncotarget 5 (6), 1646, 2014 | 202 | 2014 |
| Vaccenic acid feeding increases tissue levels of conjugated linoleic acid and suppresses development of premalignant lesions in rat mammary gland S Banni, E Angioni, E Murru, G Carta, M Paola Melis, D Bauman, Y Dong, ... Nutrition and cancer 41 (1-2), 91-97, 2001 | 194 | 2001 |
| Characterization of the biological activity of γ-glutamyl-Se-methylselenocysteine: a novel, naturally occurring anticancer agent from garlic Y Dong, D Lisk, E Block, C Ip Cancer Research 61 (7), 2923-2928, 2001 | 192 | 2001 |
| Identification of molecular targets associated with selenium-induced growth inhibition in human breast cells using cDNA microarrays Y Dong, HE Ganther, C Stewart, C Ip Cancer research 62 (3), 708-714, 2002 | 158 | 2002 |
| Widespread loss of gelsolin in breast cancers of humans, mice, and rats HL Asch, K Head, Y Dong, F Natoli, JS Winston, JL Connolly, BB Asch Cancer research 56 (21), 4841-4845, 1996 | 157 | 1996 |
| Prostate specific antigen expression is down-regulated by selenium through disruption of androgen receptor signaling Y Dong, SO Lee, H Zhang, J Marshall, AC Gao, C Ip Cancer research 64 (1), 19-22, 2004 | 156 | 2004 |
| Endoplasmic reticulum stress signal mediators are targets of selenium action Y Wu, H Zhang, Y Dong, YM Park, C Ip Cancer research 65 (19), 9073-9079, 2005 | 147 | 2005 |
| Castration-resistant prostate cancer: adaptive responses in the androgen axis A Egan, Y Dong, H Zhang, Y Qi, SP Balk, O Sartor Cancer treatment reviews 40 (3), 426-433, 2014 | 141 | 2014 |
| Selenium sensitizes MCF-7 breast cancer cells to doxorubicin-induced apoptosis through modulation of phospho-Akt and its downstream substrates S Li, Y Zhou, R Wang, H Zhang, Y Dong, C Ip Molecular cancer therapeutics 6 (3), 1031-1038, 2007 | 140 | 2007 |
| The epstein barr virus circRNAome N Ungerleider, M Concha, Z Lin, C Roberts, X Wang, S Cao, M Baddoo, ... PLoS pathogens 14 (8), e1007206, 2018 | 129 | 2018 |
| Role of androgen receptor variants in prostate cancer: report from the 2017 mission androgen receptor variants meeting J Luo, G Attard, SP Balk, C Bevan, K Burnstein, L Cato, A Cherkasov, ... European urology 73 (5), 715-723, 2018 | 125 | 2018 |
| Androgen receptor signaling intensity is a key factor in determining the sensitivity of prostate cancer cells to selenium inhibition of growth and cancer-specific biomarkers Y Dong, H Zhang, AC Gao, JR Marshall, C Ip Molecular cancer therapeutics 4 (7), 1047-1055, 2005 | 112 | 2005 |
| Methyl selenium metabolites decrease prostate-specific antigen expression by inducing protein degradation and suppressing androgen-stimulated transcription SD Cho, C Jiang, B Malewicz, Y Dong, CYF Young, KS Kang, YS Lee, ... Molecular cancer therapeutics 3 (5), 605-612, 2004 | 110 | 2004 |
| Berberine suppresses androgen receptor signaling in prostate cancer J Li, B Cao, X Liu, X Fu, Z Xiong, L Chen, O Sartor, Y Dong, H Zhang Molecular cancer therapeutics 10 (8), 1346-1356, 2011 | 108 | 2011 |
| A positive role of c-Myc in regulating androgen receptor and its splice variants in prostate cancer S Bai, S Cao, L Jin, M Kobelski, B Schouest, X Wang, N Ungerleider, ... Oncogene 38 (25), 4977-4989, 2019 | 106 | 2019 |
| Selenium disrupts estrogen signaling by altering estrogen receptor expression and ligand binding in human breast cancer cells SO Lee, N Nadiminty, XX Wu, W Lou, Y Dong, C Ip, SA Onate, AC Gao Cancer research 65 (8), 3487-3492, 2005 | 103 | 2005 |
Oliver SartorTulane University在 tulane.edu 的电子邮件经过验证
